Table of contents
OvuGel is a veterinary medicine used to synchronise ovulation in weaned sows (sows whose piglets have been taken away) for reproduction to enable artificial insemination. Because ovulation occurs as a timed response to treatment with Ovugel, a timed insemination program can therefore be used to breed sows.
OvuGel contains the active substance triptorelin (as acetate), which is a synthetic analogue of gonadotropin releasing hormone (GnRH).
OvuGel : EPAR - Medicine overview (DOCX/117.34 KB)
First published: 07/05/2021
|Agency product number||
|International non-proprietary name (INN) or common name||
Pigs (sows for reproduction)
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
|Date of issue of marketing authorisation valid throughout the European Union||
Magny Vernois 70200
10/11/2020 OvuGel - EMEA/V/C/005219 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pituitary and hypothalamic hormones and analogues
For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.